Jabra Enhance Select 200 vs Starkey Evolv AI

The Jabra Enhance Select 200 is a premium-priced OTC hearing aid that earned a B grade with a SoundScore of 3.9/5 in our lab testing, placing it in the top 35% of the OTC hearing aid category. At $1,695, this behind-the-ear device offers solid performance in several key areas, though it faces stiff competition from higher-scoring alternatives at similar price points. In our testing, this device showed particular strength in speech clarity during quiet listening situations, scoring 3.5/5—0.67 points above the category average. Own-voice comfort was another highlight at 3.4/5, finishing 0.89 points above average, which suggests users may find their own voice sounds more natural compared to many competitors. Music streaming scored 2.6/5, which is above the category average by 0.68 points but still only mixed in absolute terms. The device's limitations become apparent in challenging listening environments. Speech in noise scored just 1.4/5, slightly below the category average and low in absolute terms—a consideration for users who frequently encounter noisy restaurants or social gatherings. Feedback handling scored 4.0/5, which is strong in absolute terms though 0.54 points below the category average. The Enhance Select 200 has earned Expert's Choice Awards in both 2023 and 2024, reflecting its reliable real-world performance. With Bluetooth streaming for both iPhone and Android, rechargeable batteries, and hands-free capability, it offers modern convenience features. However, shoppers should note that several competitors in this price range—including the Lucid Tala and Audicus Omni 2—scored notably higher in our testing. This device is best suited for users who prioritize speech clarity in quieter environments and own-voice comfort over performance in noisy situations.

The Starkey Evolv AI is a premium prescription behind-the-ear hearing aid released in 2022, currently available at $4,598. In HearAdvisor's lab testing, it earns a B grade with a SoundScore of 3.9/5, ranking #30 of 39 prescription hearing aids tested. This device shows notable strengths in specific performance areas. Music streaming quality scores a solid 3.7/5, which is +0.94 points above the category average—a meaningful advantage for users who frequently stream audio from their phone. Speech in noise performance also stands out at 2.8/5, sitting +0.66 points above the category average, though this remains a mixed absolute score. Speech in quiet is solid at 3.4/5, essentially matching the category average. The Evolv AI does show some limitations in our testing. Own voice comfort scores 2.1/5, falling -0.60 points below the category average, which may affect how natural your own speech sounds. Feedback handling presents a more significant gap: while the 3.5/5 score is solid in absolute terms, it sits -1.22 points below the category average of 4.72/5, meaning competing prescription devices generally perform better in feedback stability tests. Professional fitting makes a meaningful difference with this device. The normalized Initial Score of 3.8/5 improves to 4.2/5 after tuning, a +0.4 point gain primarily driven by improvements in speech clarity metrics. At this premium price point, several competitors like the Phonak Sphere Infinio and Oticon Intent deliver higher overall scores. The Evolv AI is best suited for users who prioritize music streaming quality and speech understanding in noise, and who have access to professional fitting services to optimize performance.